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Abstract
Background: In inflammatory bowel disease (IBD), genetic susceptibility together with environmental factors disturbs gut
homeostasis producing chronic inflammation. The two main IBD subtypes are Ulcerative colitis (UC) and Crohn’s disease
(CD). We present the to-date largest microarray gene expression study on IBD encompassing both inflamed and un-
inflamed colonic tissue. A meta-analysis including all available, comparable data was used to explore important aspects of
IBD inflammation, thereby validating consistent gene expression patterns.
Methods: Colon pinch biopsies from IBD patients were analysed using Illumina whole genome gene expression technology.
Differential expression (DE) was identified using LIMMA linear model in the R statistical computing environment. Results
were enriched for gene ontology (GO) categories. Sets of genes encoding antimicrobial proteins (AMP) and proteins
involved in T helper (Th) cell differentiation were used in the interpretation of the results. All available data sets were
analysed using the same methods, and results were compared on a global and focused level as t-scores.
Results: Gene expression in inflamed mucosa from UC and CD are remarkably similar. The meta-analysis confirmed this. The
patterns of AMP and Th cell-related gene expression were also very similar, except for IL23A which was consistently higher
expressed in UC than in CD. Un-inflamed tissue from patients demonstrated minimal differences from healthy controls.
Conclusions: There is no difference in the Th subgroup involvement between UC and CD. Th1/Th17 related expression, with
little Th2 differentiation, dominated both diseases. The different IL23A expression between UC and CD suggests an IBD
subtype specific role. AMPs, previously little studied, are strongly overexpressed in IBD. The presented meta-analysis
provides a sound background for further research on IBD pathobiology.
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Introduction
The term inflammatory bowel disease (IBD) mainly covers
ulcerative colitis (UC) and Crohn’s disease (CD). IBD is a global
health problem, with a reported prevalence as high as 568 and
827 per 100 000 in USA and Europe, respectively[1]. In IBD
genetic susceptibility together with environmental factors disturbs
intestinal homeostasis, resulting in repeated inflammation-remis-
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sion cycles. CD can manifest itself anywhere in the gastrointestinal
tract, while UC is only seen in the colon with varying length and
degree of continuous inflammation extending proximally from the
rectum. In UC the inflammation is found in the mucosa, in CD a
deeper, often transmural inflammation with fistula formation is
seen. Several extraintestinal diseases are associated with IBD, such
as skin diseases, seronegative arthritis, uveitis and primary
sclerosing cholangitis. Long-standing UC is associated with an
increased risk of colorectal cancer. Despite the differences between
UC and CD, there are cases where a definite diagnosis cannot be
made, resulting in a diagnosis of non-specific colitis.
The coordinated effect of various T helper (Th) subtypes is
fundamental to gut homeostasis[2], and UC and CD have been
considered different with respect to Th cell activation. In mouse
models it was shown that Th1 mechanisms mediated an
inflammation similar to CD, and Th2 similar to UC[3]. In later
years the concept of Th17 cells has been introduced and it was
shown that inflammation previously attributed to Th1 could
actually be Th17-driven and that these lymphocytes played an
important role in CD[4,5]. Together with a better understanding
of the importance of Treg lymphocytes in controlling inflamma-
tion, these discoveries have made it necessary to re-evaluate the
Th1/Th2 concept of IBD [6].
Since the emergence of whole genome gene expression analysis
(WGGE), efforts have been made to identify the transcriptional
regulation underlying IBD. Although nearly a hundred suscepti-
bility SNPs for IBD have been found, there has been limited
success in translating gene expression results into hypotheses that
aid the understanding and treatment of IBD [7]. Previous work in
this field differs greatly. Gene expression technology has evolved
fromserial analysis of gene expression (SAGE), to the newest
WGGE arrays from e.g. Affymetrix and Illumina. Already in 1997
Heller et al. studied CD using spotted cDNA arrays [8]. In 2000
Dieckgraefe et al. examined colonic mucosa samples using
Affymetrix Hum 6000 arrays with a coverage of ,6500 genes
and expressed sequence tags (ESTs). This study identified 74
differentially expressed genes between inflamed UC and normal
mucosa, grouping in functional classes such as immunoregulation
and tissue regeneration [9]. Following these initial efforts many
studies have been carried out, with great variation in the approach
to the subject [10–25].
The WGGE analyses have identified regulation of several genes
involved in processes thought to be of importance for IBD. Wu et
al. suggested that genes involved in cell adhesion and polarisation
processes were down-regulated in un-inflamed UC [11]. Olsen et
al. used a set of genes to create a classification model able to
discern un-inflamed UC samples from un-inflamed CD/control
samples based on expression levels [12]. By comparing samples
from IBD patients refractory to corticosteroids and/or immuno-
suppression before and after infliximab-treatment, Arijs et al.
confirmed previous observations that expression of antimicrobial
peptide (AMP) genes is changed in IBD [14,26,27]. Other studies
have focused on identifying transcriptional regulation that could
explain the clinical differences seen between UC and CD.
However, the details around the initiation, propagation and
maintenance of the chronic inflammation in IBD remain unclear.
When studying gene expression in complex tissues, the choice of
sample material is very important. Patient and sample heteroge-
neity will greatly influence the measured expression levels, often
hindering interpretation of the differences between sample groups.
In IBD, leukocyte infiltration, Paneth cell metaplasia, crypt
hyperplasia and ulceration with loss of epithelial cells are factors
that will influence measured gene expression levels. As an
example, the increase in a-defensin expression in colonic IBD
has been attributed to colonic Paneth cell metaplasia, while the
decrease of a-defensin expression in ileal CD has been linked to
loss of epithelial tissue, Paneth cell function and NOD2 status
[14,27–29].
Another effect potentially interfering with IBD microarray
analysis is the regional variation in gene expression, with both a
dichotomous and a more gradually varying gene expression
pattern along the colon [30]. This regional variation has been
discussed in several earlier IBD gene expression studies. Wu et al.
and Costello et al. identified no such gene expression differences
due to regional variation [11,15], In a later study, Noble et al.
noted that this was readily identified in healthy controls. It is
possible that modest regional variations can be masked when
analysing inflamed tissue, but become apparent when un-inflamed
biopsies are studied. These observations emphasize the importance
of avoiding, or being aware of, confounding effects in the analysis
of subtle differences in expression.
In this paper, a microarray-based gene expression analysis of
colon pinch biopsies from IBD patients is presented. It is to the
best of our knowledge the largest such study undertaken including
samples from both inflamed and un-inflamed mucosa from UC
and CD patients as well as normal controls. All un-inflamed
samples and controls were obtained from the hepatic flexure,
minimising any regional effect. The analysis was further supple-
mented by a meta-analysis of available IBD WGGE data, placing
the presented data in the context of previous research on key fields
in IBD research; T helper cell activation and antimicrobial peptide
expression. The approach used in this work is meant to overcome
the challenges of sample size, and heterogeneity in patients and
sample material typically seen in gene expression analysis of
complex, multifactorial diseases. By exploring the consensus
between several data sets for expression related to important
aspects of IBD, this analysis serves as a robust validation of
suggested hypotheses
Results and Discussion
Gene expression analysis – NTNU data
Clinical material. All biopsies were assessed as either
diseased or normal based on endoscopic findings at time of
collection. Final diagnosis was done by histopathological evalua-
tion of H–E stained sections. In cases where there was a
discrepancy between endoscopic and histological assessment, the
sample was excluded from the analysis. Moreover, 6 patients were
excluded after a diagnosis of indeterminate colitis. A summary of
sample information is provided in Table 1. Full information on the
samples used in the analysis is included in Table S1. The final
sample population consisted of 20 healthy controls (N), 37 active
ulcerative colitis (UC), 7 active Crohn’s disease (CD), 44 un-
inflamed ulcerative colitis (UCU) and 19 un-inflamed Crohn’s
disease (CDU) samples. UCU sample group was further divided in
two groups based on patient history. Samples originating from
patients where sampling area (hepatic flexure) had previously been
diagnosed as inflamed (UCUi, 11), and samples where no
inflammation of the sample area ever had been observed (UCUu,
23).
Microarray gene expression analysis. Data analyses were
performed using Bioconductor for the R software environment
(http:www.r-project.org)[31]. Two samples, 226F and 115F, were
analysed 8 times on separate chips as technical controls, showing
good correlation between technical replicates (226F r2 = 0.989,
115F r2 = 0.992). In the final analysis the replicate closes to
median of all replicates was used. Principal component analysis
(PCA) analysis identified inflammation status as the dominating
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variation in the dataset, separating CD/UC samples from N/
UCU/CDU as shown in Figure 1A. There was no apparent
separation between UC and CD in the PCA analysis. T-testing
identified 4187/4189 significantly down/up-regulated genes for
inflamed tissue from UC patients (UC), and 2093/2134 for
inflamed tissue from CD patients (CD). For un-inflamed tissue
(UCU and CDU), a very low number of differentially expressed
genes were found (0/3 CDU, 0/0 UCU). Similarly to what was
seen for the collected group, no differential expression was
detected for the groups UCUi and UCUu when contrasted
against normal controls (data not shown). The latter observation
stands in contrast to recent finds reported by Planell et al,
demonstrating several thousand genes as differentially expressed
between UCUi and N[32]. This discrepancy is thought to arise
due to differences in sample inclusion criteria. The complete table
of results from the analysis is available in Table S2.
A Venn diagram illustrating the relationship between genes
differentially expressed in UC and CD is given in Figure 1B. Using
normal samples as common reference identified 4063 differentially
expressed genes as common for CD and UC, with 4313 unique for
UC and 164 unique for CD. This was in contrast to an analysis of
CD vs. UC without use of common reference which identifies only
10 differentially expressed genes, of which 7 were included in the
two previous analyses. This discrepancy could arise as a result of
the imbalance in sample sizes. As the UC sample number is
approximately 4 times larger than the CD sample size the variance
of UC group is lower, giving higher t-scores in the analysis.
Other gene expression studies of IBD mucosal samples have
reported expression differences between UC and CD, and built
classifiers based on these results [10,12,24]. All of the classifiers are
yet to be confirmed in clinical practice. Based on this observation
of similarities between UC and CD gene expression, we chose to
focus on defining the consensus set of genes and processes
describing IBD, as observed when using whole genome gene
expression analysis.
UC and CD samples share similar expression patterns
related to T helper cell subtypes. Disease-specific gene co-
expression networks were generated by computing Pearson
correlation coefficients for the 4227 and 8376 differentially
expressed genes in CD and UC respectively. Network analysis
for un-inflamed tissue was not undertaken due to low numbers of
differentially expressed genes. For each inflamed network,
correlations were measured across normal and disease tissue.
The CD-specific network (CD.N) and UC-specific network
(UC.N) were partitioned into 13 and 9 modules with at least 30
genes. The largest modules in CD.N and UC.N contained 1261
and 4500 genes respectively. Subsequently, an enrichment analysis
of each module identified over-represented Gene ontology (GO)
terms. The complete lists of enriched GO processes are provided
in Table S3 (for CD.N) and Table S4 (for UC.N). To
computationally estimate functional similarities between CD.N
and UC.N modules, Jaccard coefficient was calculated for all
module pairs identified by the WGCNA. The largest overlap was
observed between CD.N module 7 and UC.N module 3 (Jaccard
= 0.14), enriched for ‘‘T cell activation’’. This similarity between
‘‘T cell activation’’ modules prompted further analysis of gene
expression related to T cell differentiation in UC and CD.
The nature of T helper cell development in IBD has been an
area of discussion for several years. The predominating theory has
been that the adaptive immune response in CD is dominated by
Th1 lymphocytes and in UC by Th2 lymphocytes. The
identification of Th17 as a unique subset of T helper cells has
challenged this view, and today some argue that the adaptive
immune response in CD, and to some degree UC, is dominated by
Th1/Th17 cells [6]. However, there are still unanswered questions
regarding the role of Th2 activation in UC. A set of genes whose
expression is known to be related to the four T helper cell lines
Th1, Th2, Th17 and Treg were collected. Extracting the
differential expression levels given as log2 fold change (log2 FC)
and corrected p-values (p) for these genes allows for a character-
ization of T helper cell function in IBD.
Th1-related transcription factors STAT1 (log2 FC: 1.62/1.64
for CD/UC, p,0.001) and STAT4 (log2 FC: 0.55/0.76,
p,0.005), as well as the classical Th1 cytokine IFNG (log2
FC:0.76/1.09, p,0.001) show increased expression in both CD
and UC, a pattern expected during an active Th1 response. This is
further supported by the increased expression of CXCR3 (log2 FC:
0.54/0.42, p 0.001/,0.001), a Th1-associated chemokine recep-
tor[33]. Interestingly there was a small increase in expression of
the Th2 transcription factor GATA3 in UC (log2 FC: 0.11, p:
0.01), but no increase in IL4 or STAT6 expression, suggesting an
IL4/STAT6-independent activation of the Th2-related transcrip-
tion factor GATA3. Jenner et al. has suggested an explanation for
this unsupported expression of GATA3 by demonstrating that
GATA3 may also be expressed in Th1 cells[34]. In this study
GATA3 was shown to bind to the promoters of Th1-related genes
in a pattern similar to that of the Th1 transcription factor TBX2,
suggesting that the absence or presence of TBX2 determines cell
lineage [34,35].
Table 1. Summary of sample information.
N CD UC CDU UCU
Number of subjects 20 7 37 19 44
Age, median years
(range)
45 (19–71) 31(20–41) 38(19–72) 39(20–61) 45 (21–71)
Female / Male 9/11 2/5 22/15 6/13 24/20
Duration of disease,
median years (range)
NA 7 (1–12) 9 (0–40) 6 (0–28) 13 (0–40)
5-ASA/S-ASA (%) 0 2 (29) 23 (62) 6 (32) 27 (61)
Systemic corticosteroids
(%)
0 2(29) 9(26) 8 (42) 4(9)
Each column summarizes characteristics for all patients contributing with samples to the corresponding sample groups. 5-ASA – 5-aminosalicylic acid. S-ASA –
sulphasalazine. Sample groups are abbreviated N for normal controls, CD for Crohn’s disease, UC for ulcerative colitis, CDU for un-inflamed Crohn’s disease and UCU for
un-inflamed ulcerative colitis.
doi:10.1371/journal.pone.0056818.t001
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Th17-associated genes are up-regulated in both CD and UC
mucosa. The effector cytokines IL17F (log2 FC: 0.37/0.24,
p,0.002), IL26 (log2 FC: 0.23/0.24, p: 0.03/,0.001) and TNF
(log2 FC: 0.49/0.73, p: 0.01/,0.0001) were all up-regulated in
CD and UC, suggesting the presence of active Th17-cells in the
inflamed mucosa of IBD patients. This is further supported by the
overexpression of Th17-associated transcription factors STAT3
(log2 FC: 0.57/0.58, p,0.001) and RORA (log2 FC 0.54/0.48, p:
(0.002/,0.001). The cytokines IL1A (log2 FC: 1.01/1.45,
p,0.001), IL1B (log2 FC: 2.38/3.07, p,0.001) and IL6 (log2
FC: 0.65/1.14, p: 0.01/,0.001), known to stimulate Th17
differentiation, were also up-regulated in IBD tissue[36]. Both
Th17-associated chemokine-receptors CCR4 (log2 FC: 0.26/0.24,
p 0.008/,0.001) and CCR6 (log2 FC: 1.01/0.93, p,0.001), and
the Th-17 associated receptor KLRB1/CD161 (log2 FC: 0.83/
0.73, p 0.02/,0.01) are differentially expressed in both CD and
UC, further substantiating the validity of this observation[37,38].
There is little classical Treg-related expression, with only
STAT5A exhibiting a marginal up-regulation in CD and UC
(log2 FC: 0.35/0.50, p ,0.05). However, both subunits of the
Treg-cytokine IL35, IL12A (log2 FC: 0.17/0.24, p 0.02/0.002)
and EBV3 (log2 FC: 0.95/0.81, p ,0.001), were over-expressed,
while their other potential co-factors, IL12B and IL27A, had no
significant increase in expression. IL35 is a newly discovered
cytokine produced by T regulatory cells [39,40]. A Spearman
correlation analysis of the subunits corresponding to IL27 (IL27A
and EBI3), IL35 (EBI3 and IL12A), IL23 (IL23A and IL12B) and
IL12 (IL12A and IL12B) had the following rho values; IL27:0.04,
IL23:0.003, IL12: 0.13 and IL35: 0.41. This could suggest an
IL35-mediated Treg activity in the inflamed mucosa of IBD
patients.
An interesting distinction between UC and CD expression was
seen in IL23A-expression, with a significant log2 FC of 0.92 in UC
but no significant difference in CD. The other subunit of IL23,
IL12B, exhibited no DE in either UC or CD. However, one
cannot exclude differential expression of IL12B, as expression
levels are below the detection limits in the microarray analysis.
Overall, the interpretation of the data in this setting confirms
differentiation of activated T cells to Th1 and Th17 cells in both
UC and CD, with an apparent absence of Th2-related differential
expression. The expression profile of the selected genes in UC and
CD are similar in this study, suggesting similar T helper cell
population in the mucosa, at least under chronically active
conditions.
Antimicrobial peptide genes are overexpressed in both
UC and CD. There is increased expression of many AMPs in
both inflamed UC and CD mucosa, with only a few interesting
exceptions. Defensin 1 beta (DEFB1) is significantly down-
regulated in both UC (log2 FC -2.19) and CD (log2 FC -1.89),
while the gene encoding liver expressed antimicrobial protein 2
(LEAP2) showed a similar, but less prominent regulation (UC: log2
FC -0.78, CD: log2 FC -0.68). The loss of DEFB1 expression has
previously been reported by Arijs et al., who suggested that
alterations may be due to a loss of epithelial tissue in inflamed
colon [21]. Our results suggest an alternative explanation. A work
by Peyrin-Biroulet et al. describes the role of DEFB1 in
maintaining homeostasis, and explores the regulation of colonic
DEFB1 expression[41] The study demonstrates that DEFB1
expression is under transcriptional control of PPARG. There
was a significant down-regulation of peroxisome-proliferator
receptor gamma (PPARG) in both UC (log2 FC -1.35) and CD (-
1.14), and a strong correlation (rho 0.73) between expression of
PPARG and DEFB1 suggesting that DEFB1 down-regulation could
be a result of loss of PPARG expression. However, further
exploration is needed to conclude with a causal effect of the
observed correlation.
Figure 1. Initial analysis of NTNU data set. A: PCA analysis of NTNU data set. Each point represents one sample, with colour indicating sample
groups as described in figure legend. Axis indicate % of total variance explained in each component. B: Venn diagram illustrating the relationship
between analyses of sample groups UC and CD directly and using N as common reference. Numbers indicate significant genes (corrected
p-val,0.05).
doi:10.1371/journal.pone.0056818.g001
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Meta-analysis - NTNU data and publicly available datasets
Meta-analysis shows intra-experiment differences in
power, but good correlation in regulation. Data from all
available datasets fulfilling the search criteria defined in the
methods section were included in a meta-analysis to identify gene
regulation and processes that were stably correlated with disease
status over many analysis settings. The rationale was that
regulation consistently identified over a cross-platform, cross-
laboratory meta-analysis could be seen as externally verified,
thereby increasing the validity of conclusions. Details of the
datasets are provided in Table 2. The comparisons were
performed both on the gene expression and GO category levels.
For the gene level analysis, comparisons were made between both
t-score (Figure S1) and by ranking of genes (Figure S2). The rank-
based analysis was used to identify an appropriate number of genes
to use in the t-score analysis. The number of genes used was
chosen based on the top union score of the rankings, as calculated
using GeneSelector[42]. The gene comparison demonstrated a
wide distribution in the statistical power of the tests performed,
with a spread in differentially expressed genes from 7500 to 30 in
the comparison UC vs. N. All sets containing both UC and CD
samples exhibited a higher number of DE genes for the UC vs. N
test than CD vs. N test. However, the cluster analysis does not
identify a separation between UC and CD on the basis of mucosal
gene expression. For tests of un-inflamed tissue vs. normal there
was little consensus, suggesting that each of these tests capture
different variation. For comparisons of tests of inflamed tissue vs.
normal there was a good agreement between the sets with regard
to t-scores, the closest clustering involving inflamed tissue.
There was a high ‘‘intra-experiment’’ similarity, with lists from
the same study clustering as neighbours independently of
diagnosis. Strong tests of inflamed vs. un-inflamed samples with
many DE genes clustered together. The strength of the sets
appeared to be the product of two parameters; many samples or
well controlled sample groups. Ahrens et al. have relatively few
samples (13 patients) in their UC group, but many DE genes in the
UC vs. N comparison (.7500) were identified. The samples used
in this comparison were uniquely controlled, with a focus on un-
medicated paediatric patients. In the dataset collected by Arijs et
al. all samples had high degree of inflammation, taken from
patients’ refractory to corticosteroids/immunosuppressant[21]. In
our dataset the number of inflamed UC samples was 37, a number
of samples that was sufficient to compensate for the relative
heterogeneity in sample set, and resulted in a set of approx. 7500
DE genes.
Some comparisons were divergent. The UCU vs. N test based
on samples from Olsen et al. cluster with the affected group,
showing high t-scores for genes typically DE in inflamed tissue.
This corresponded well with conclusions in the article describing
the dataset, suggesting a pre-inflammatory state in un-inflamed
tissue from patients diagnosed with UC[12]. The expression
pattern seen in this set of sample was however not reproduced in
the other sets of unaffected samples.
Gene set analysis of imported data sets identifies
consensus processes important in IBD pathology. By using
gene set enrichment analysis the results from all the data sets could
be compared at a more general level, potentially identifying the
fundamental processes underpinning IBD. This reduction into GO
categories also helped overcome difficulties in comparing results
from many analyses, as similarities in a gene category could be
found even when methodological differences limited any gene-for-
gene comparison [43]. An initial analysis was undertaken to
identify the appropriate number of GO categories to use in the
comparison. The result from this analysis is provided in Figure S3.
Figure 2 is a summary of the finds, where categories were chosen
on the basis of all data as outlined in the methods section. In this
figure all GSEA scores were included, regardless of q value. A
supplementary figure with a q value cut-off of 0.25 was included as
Figure S4. The analysis showed few gene sets with a significant
normalised enrichment score (NES). However, as is seen in
figure 2, there is a remarkable consistency in the NES for top
ranked categories across studies, suggesting that similar processes
are dominating all gene lists based on inflamed samples. As was
demonstrated in the t-score based analysis, the cluster analysis
readily separated inflamed from un-inflamed comparisons, show-
ing little separation of CD and UC sets. The separation between
strong and weak data sets was also repeated.
The list of GO categories was dominated by inflammation-
related categories both related to innate and adaptive immunity
responses. There were several categories describing cell prolifer-
ation, thought to be activated due to the increase in epithelial cell
regeneration as a response to tissue damage. Interestingly, several
categories related to angiogenesis were broadly activated,
supporting the notion that this may be an important process in
IBD[44].
Both T helper cell and AMP observations are confirmed
by meta-analysis. GSEA analysis based solely on categories
related to T helper cell differentiation was performed as described
in the methods section. A plot of mean NES scores for UC and
CD is given in Figure 3. A Wilcox rank-sum test between UC and
CD for each gene category demonstrated no significant difference
in NES score for UC and CD. The analysis demonstrated the
highest mean NES score for Th1 and Th17-related categories,
while the Th2-related categories showed the lowest mean GSEA
score for both UC and CD. The GATA3 category showed the
largest difference in activity when comparing UC and CD. Of all
the categories, this also has the smallest p-value (0.1).
Two lists of gene names were assembled to further investigate T
helper cell differentiation and AMP expression in inflamed colonic
IBD mucosa. The list of AMPs was based on work by Arijs et
al[21]. here was a broad consensus between gene regulation
observed in the presented dataset and the meta-analysis both in
the subset of T helper cell-associated and AMP genes. Two heat
maps were constructed from each gene set, one using only
significant t-scores and one with all t-scores irrespective of
significance, the rationale being that even non-significant regula-
tion could help interpretation when supported by significant
regulation in other analyses. Figures based on scores with
corrected p-value ,0.05 are included as Figures 4 and 5. The
figures based on all scores are given as Figure S5 and S6. Applying
p-value cut-off reveals the lack of statistical significance of observed
gene regulation for many of the data sets.
The observations made based on our dataset were broadly
confirmed by all imported datasets, even when t-scores were not
significant. There were few differences in t-scores between UC and
CD. IL23A expression was only identified as significantly increased
in UC vs. N tests. This was an interesting finding when viewed in
the light of previous research exploring the IL23-axis in IBD
[45,46]. Animal models have suggested an important role for IL23
in Th17 proliferation, and an IBD-susceptibility SNP has been
identified in the IL23 receptor [46,47]. The different IL23A levels
detected in inflamed tissue from UC and CD patients suggest
distinct roles for this cytokine in the two diseases. Our dataset is
the only analysis showing a DE for IL6 in CD vs. N, with all other
DE shown in UC vs. N tests. Our set together with the data of
Noble et al. also identified a DE of IL17F, while the other data sets
found IL17A as DE. A possible explanation for this might be
differences in technology, as IL17F was found DE on Affymetrix
Dissecting the IBD Transcriptome
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chips, while IL17A was found on Agilent and Illumina micro-
arrays.
An interesting observation was the down-regulation of RORC.
RORC is seen as a key transcription factor for Th17 cells, that
together with STAT3 and RUNX1 promotes the transcription of
the effector cytokines IL17A/F, IL21, IL22, IL26 and CCL20[48].
This down-regulation was unexpected, as both key regulators of
RORC expression (TGFB and STAT3), the transcription co-factors
Figure 2. GSEA analysis of all data sets. The figure shows a heat map of GSEA scores for the GO categories selected in the rank-based analysis.
Each column in the figure represents the result for one comparison against normal control, with sample source and test group given as column
name. The connection between each columns source abbreviation and its related dataset(s) and article(s) are given in table 2.
doi:10.1371/journal.pone.0056818.g002
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(RUNX1 and STAT3) and the effector cytokines were all over-
expressed in many of the datasets included in the analysis.
However, the closely related paralog to RORC, RORA, was over-
expressed in several datasets. Studies in mice have demonstrated
that RORA expression is sufficient to promote Th17 differenti-
ation, possibly explaining the regulation seen in this meta-
analysis[49]. It must also be stressed that even though there was
a down-regulation of RORC expression, there was no evidence of
loss of RORC function, possibly suggesting that the relative down-
regulation is not enough for RORC to be a limiting factor in the
combined transcriptional regulation of RORC, RORA, RUNX1
and STAT3. Interestingly, the sets showing the most distinct
regulation of RORC was based mainly on un-medicated paediatric
patients (Ahrens et al. and Carey et al.), together with data from
Kugathasan et al. where no patient age information was given.
The same datasets also showed no significant regulation of STAT3.
Almost all datasets exhibited over-expression of suppressor of
cytokine signalling 3 (SOCS3), a gene closely associated with Th2
cell development, while there was a broad down-regulation of
other Th2-associated transcription. This apparent paradox has
been observed in CD before[50]. It might arise due to another role
of SOCS3, namely as an inhibitor of naı¨ve CD4+ cell
differentiation to activated T cells. SOCS3 inhibits the production
of IL-2, a cytokine crucial for the activation of T cells, effectively
inhibiting initial T cell activation. The over-expression of SOCS3 in
this setting might therefore be the result of an effort to limit the
activation of T helper cells in the inflamed mucosa, while the
increased expression of STAT3 might be the result of SOCS3-
independent activation via IL10[51,52]. It is also possible that the
SOCS3 expression detected stems from cells other than the
lymphocytes, as both neutrophils, macrophages and epithelial
cells have been shown to express SOCS3 in IBD mucosa[53].
In the AMP set the pattern of expression seen in our dataset was
reproduced in the imported sets as shown in Figure 5. The two
down-regulated AMPs DEFB1 and LEAP2 exhibited similar down-
regulation in the other sets, while at the same time confirming the
observed up-regulation of AMPs in inflamed mucosa. The down-
regulation of PPARG was also broadly confirmed in the imported
data (data not shown).
Conclusion
The present study is the to-date largest microarray gene
expression study examining both inflamed and un-inflamed
samples from colonic mucosa of IBD patients. Uniquely, the
analysis also includes a gene co-expression network analysis and a
meta-analysis of comparable IBD datasets. The analysis shows a
similarity between the gene expressions in inflamed mucosa from
UC and CD patients, which is confirmed by hierarchical
clustering of several independent data sets. This suggests that
once established the inflammatory mechanisms at mucosal level
are largely the same for the two diseases. Our analysis further
demonstrates that the T helper cell-related expression found in the
inflamed colonic mucosa of all IBD patients is dominated by Th1/
Th17-related expression, with little to no signs of Th2 differen-
tiation. There was no significant difference between GSEA scores
for T helper cell related categories between UC and CD. The
mean GSEA score was highest for categories related to Th1/
Th17, and lowest for Th2-related categories. The only selected
gene showing a clear difference in expression between UC and CD
was IL23A, consistently showing DE in UC vs. N comparisons.
This distinction between UC and CD T cell expression seems to
be highly reproducible, and is of particular interest given previous
research emphasising the importance of the IL23-axis in IBD.
Another feature very similar across the diagnoses and the different
datasets is the significant change in expression of antimicrobial
peptides, the AMPs. The expression of many AMPs in inflamed
IBD mucosa is generally increased when compared to un-inflamed
mucosa, with the exception of DEFB1 and LEAP2. In the in-house
data, the loss of DEFB1 is highly correlated with loss of PPARG
expression, a gene known to exert a promoting effect on DEFB1.
In addition, mucosal biopsies from un-inflamed colon in patients
with IBD had gene expression patterns almost identical to healthy
control subjects, with only CDU displaying a few differentially
expressed genes in the NTNU dataset.
This IBD WGGE study for the first time integrates external
data sets, providing a sound background for further research on
IBD pathobiology. The chosen strategy of focusing on consensus
Figure 3. T helper cell associated GSEA analysis. A subset of gene categories thought to represent T helper cell differentiation was selected
from MSigDB. The bar plot is a summary of results from GSEA analysis of this subset, where each bar represents the mean GSEA score for a sample
group (UC or CD) for the GSEA category in question. A Wilcox rank-sum test was performed between disease groups fails to identify a difference
between GSEA scores for the selected categories.
doi:10.1371/journal.pone.0056818.g003
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Figure 4. T helper cell-associated genes. The figure shows a heat map of t-scores (corrected p-val ,0.05) for genes related to T helper cell
differentiation and function. Figure S4 shows the same data with a no p-value cut-off. Genes are grouped in the Th sub-categories Th1, Th2, Th17 and
Treg. Each column in the figure represents the result for one comparison against normal control, with sample source and test group given as column
name. The connection between each column’s source abbreviation and its related dataset(s) and article(s) are given in table 2. Some sets lack
measurements for certain genes, in which case a grey marking is used.
doi:10.1371/journal.pone.0056818.g004
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genes and processes over several datasets facilitates result
interpretation and validation.
Materials and Methods
Sample material
Samples were collected from an IBD cohort at St. Olav’s
University Hospital, Trondheim, Norway. Study participants were
patients admitted to the Department of Gastroenterology for
colonoscopy. Participants were either diagnosed with UC or CD,
or were admitted for diagnostic colonoscopy due to symptoms
unrelated to IBD. Patients were only included as normal controls
after all clinically indicated examinations had concluded no signs
of gastrointestinal disease. In the IBD groups (UC and CD), four
endoscopic pinch biopsies were taken from macroscopically
maximally inflamed mucosa, as well from the hepatic flexure in
cases where this was found to be macroscopically un-inflamed UC
unaffected (UCU) and CD unaffected (CDU)). Two UCU
samples, 228 F and 118 F were obtained from ascending colon
Figure 5. Antimicrobial peptide gene expression. The figure shows a heat map of t-scores (corrected p-val ,0.05) for genes coding for known
antimicrobial peptides. Figure S5 shows the same data with no p-value cut-off. Each column in the figure represents the result for one comparison
against normal control, with the sample source and test group given as column name. The connection between each column’s source abbreviation
and its related dataset(s) and article(s) are given in table 2. Some sets lack measurements for certain genes, in which case a grey marking is used.
doi:10.1371/journal.pone.0056818.g005
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and rectum, respectively. For the normal (N) group, four biopsies
were taken from the hepatic flexure. One biopsy from each area
was fixed in 4% buffered formaldehyde, while the three remaining
biopsies were snap frozen and stored in liquid nitrogen.
Ethics statement
Written informed consent was obtained from all participants,
and the study was approved by the Regional Medical Research
Ethics Committee (approval no 5.2007.910). The study was
registered in the Clinical Trials Protocol Registration System
(identifier NCT00516776).
Microarray analysis
RNA extraction and quality control. Frozen biopsies were
homogenized in lysis buffer using a rotating knife homogenizer
(Zanke & Kunkel IKA-Laboratorie Technik, Staufen, Germany).
Total RNA was extracted using the Ambion mirVana miRNA
Isolation Kit (Applied Biosystems, CA, USA). Quality control was
performed for each extract. Quantity and purity of RNA was
assessed using a NanoDrop Spectrophotometer (Thermo Scientif-
ic, DE, USA), and the integrity of isolated RNA was determined
using Bioanalyzer (Agilent Technologies, CA, USA). Samples were
only included in subsequent analysis if the RIN value. 7. Isolated
RNA was stored in cryo-tubes in liquid nitrogen.
Hybridization. 250 ng total RNA from each sample was
used to generate biotinylated, amplified cRNA using the Illumina
TotalPrep RNA Amplification kit (Applied Biosystems/ Ambion,
Austin, TX, USA). cRNA was stored at 280uC, and the
concentration of each cRNA sample was adjusted to 150 ng/ ml
prior to hybridization. The samples were all hybridized in parallel
on Illumina human HT-12 expression BeadChips (Illumina, San
Diego, CA, USA) and scanned on an Illumina BeadStation.
Results from the microarray analysis are available at ArrayExpress
E-MTAB-184.
Differential expression analysis
Expression data analysis was performed using the R software
environment for statistical computing[54]. Methods supplied in
the Bioconductor package were used for import, quality assess-
ment, normalization, filtering and statistical analysis of the
expression data [31]. Data was log-transformed and quantile
normalized. Probes not corresponding to an ENTREZ ID were
removed. In cases where several probes corresponded to one
ENTREZ ID, the probe showing the highest variance over all
samples was chosen for further analysis. Initial interpretation of
data was done using the unsupervised method of Principal
Component Analysis (PCA). Final differential expression analysis
was performed using LIMMA linear models with least squares
regression and empirical Bayes moderated t-statistics[55]. P-values
were adjusted for multiple comparisons using the Benjamini
Hochberg false discovery rate correction (FDR). A corrected p-
value of 0.05 was chosen as significance level.
Network analysis
Weighted correlation network formation. From the nor-
malized microarray dataset we followed the protocol for Weighted
Correlation Network Analysis (WGCNA) [56,57] to create CD-
and UC- specific networks. For each network, only DE genes
(Bayes moderated p-values ,0.05) in diseased compared to
normal samples were analysed and co-expressions were measured
across normal and diseased tissue.
Genemodule detection, comparison, and enrichment. Genes
were hierarchically clustered using 1 – Topological Overlap (TO) [58] as
the distance measure and modules were determined by applying a
dynamic tree-cutting algorithm [56]. TO is a biologically meaningful
measurement that reflects the similarity of gene co-expression relation-
ships in the network, while the dynamic tree-cutting algorithm allows
identification of clusters in a dendrogram depending on their shape.
Similarity between CD and UC disease modules was expressed using the
Jaccard coefficient - the ratio of the number of genes common to two
modules to the number of total genes in both modules. All modules were
enriched for over-represented Gene Ontology (GO) functional terms
using the Fisher exact test. As background we used all of the supplied
genes that were present in at least one term in the GO.
Meta-analysis of available data sets
Choosing data sets for meta-analysis. The microarray
data repositories Array Express and NCBI GEO were searched for
datasets containing references to ‘‘Inflammatory bowel disease’’,
‘‘Ulcerative colitis’’ or ‘‘Crohn’s disease’’ [59,60]. These datasets
where then evaluated further by including only analyses done on
pinch biopsies from human colon. Data from printed arrays
(oligo/cDNA microarrays) were excluded. Only sets where at least
one of the groups UC, CD, UCU, CDU in addition to control
individuals (N) were included. The total number of external
datasets included in the analysis was 10. A full list of included data
sets is given in Table 2
Differentially expressed genes meta-analysis. We used
the limma software package (ver. 3.12.1) from Bioconductor to
assess the effect of DE of IBD subgroups with respect to normal
controls. The individual contrast for each dataset was summarised
by t-scores and adjusted p-values in the same manner as the
original analysis of our data. All analyses following this were based
on the resulting ‘‘gene x contrast’’ matrix, where each contrast
from each set was represented with two tables containing t-scores
and p-values. We determined an aggregated rank score for each
gene by a weighted-mean summary across the ranks of inflamed
(UC, CD) t-scores. In this method, the weights received are
proportional to the logarithm of the number of genes identified as
significant in the limma-model, with a minor moderation to
accommodate small values. In cases where only a subset of the
datasets (due to differences in array types) have a specific gene
present we used imputed values for the missing t-scores based on a
k-nearest neighbour imputing scheme as implemented in the
impute (ver. 1.30.0) Bioconductor package. The imputed values
were subsequently removed prior to results visualization.
The (genes x contrasts) table of ranks was visualised as a heat
map with genes ordered after aggregated rank score and contrasts
ordered by distance to the aggregated rank score. The distance
was calculated using linear decay weighting of the Manhattan
distance as implemented in the default settings of the GeneSelector
package (ver. 2.6.0) and a unionscore was computed from the
same package using only the inflamed contrasts. The unionscore
measures the similarity between multiple ordered lists by counting
the size of the union for each position in the aggregated rank score
and normalising with regards to position. A high unionscore
indicates high agreement between contrasts. The maximum
unionscore was achieved at position 2973 and thus the first 2973
genes were selected for visualising t-scores. The t-scores were
visualized in a heat map where both rows and columns were
ordered by hierarchical clustering using Euclidean distance and
Ward agglomeration. Gene ontology GSEA meta-analysis
A GSEA (Gene Set Enrichment Analysis) score was estimated
for each of the individual contrasts. The more recent version
weighted with correlation to phenotype was used and gene sets
were collected from the GO Biological Process part of MSigDB
(ver. 3.1) [61]. This relatively reduced set of categories was chosen
to improve interpretation, as the goal was not mainly to identify
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novel categories but rather to provide a well validated represen-
tation of the processes at hand in colonic IBD inflammation. A
gene set was accepted if it contained between 25 and 1500 genes.
Categories were further filtered on q value, including only
categories where at least 3 comparisons had q values , 0.25.
This resulted in a list of 233 categories. These categories were
included in the union score calculation as described for the gene-
wise analysis, this time based on ranked q values identifying 33
categories with the top union score. The results were visualised as
in the gene meta-analysis. A second GSEA analysis was performed
on a subset of the MSigDB categories related to T helper cell
differentiation. These categories were ‘‘Biocarta GATA3 path-
way’’, Biocarta IL12 pathway’’, ‘‘Biocarta IL17 pathway’’,
‘‘Biocarta IL4 pathway’’, ‘‘Biocarta Th1Th2 pathway’’, ‘‘Biocarta
IL4 pathway’’ and ‘‘Der INF gamma response up’’. A GSEA score
was calculated for each of the contrasts, and mean GSEA score for
UC and CD contrast were calculated for each category. A Wilcox
rank-sum test was performed between GSEA scores for UC and
CD.
Supporting Information
Figure S1 T-score analysis of all data sets. A visualisation
of the top scoring genes over all available data sets. Each column
represents one comparison, with sample group and source given in
the column name. Each vertical line represents a t-score from the
corresponding analysis. Grey lines replace missing values, where
no measurement of the gene in question was given in the source
data. The connection between each columns source abbreviation
and its related dataset(s) and article(s) are given in table 2.
(TIF)
Figure S2 Gene rank analysis of all data sets. Figure
illustrating the method used to choose the number of genes used in
t-score based comparison of all data sets. Optimal number of genes
was chosen at the maximum unionscore as described in Methods
section.
(TIF)
Figure S3 GO rank heat map. GO rank analysis: Figure
illustrating the method used to find the optimal number of GO
categories to use in a comparison of all data sets. The optimal
number of GO categories (33) was chosen at maximum unionscore
as described in methods section.
(TIF)
Figure S4 GSEA analysis of all data sets with q value
cut-off. The figure shows a heat map of GSEA scores for the GO
categories selected in the rank-based analysis. Each column in the
figure represents the result for one comparison against normal
control, with sample source and test group given as column name.
Scores with q-value . 0.25 are removed. The connection between
each columns source abbreviation and its related dataset(s) and
article(s) are given in table 2.
(TIF)
Figure S5 T helper cell associated genes. Figure shows a
heat map of significant t-scores for genes related to T helper cell
differentiation and function. Genes are grouped in the Th sub-
categories Th1, Th2, Th17 and Treg. Each column in the figure
represents the result for one comparison against normal control,
with sample source and test group given as the column name. The
connection between each column’s source abbreviation and its
related dataset(s) and article(s) are given in table 2. Some sets lack
measurements for certain genes, in which case a grey marking is
used.
(TIF)
Figure S6 Antimicrobial peptide gene expression. Figure
shows a heat map of significant t-scores for genes coding for known
antimicrobial peptides. Each column in the figure represents the
result for one comparison against normal control, with sample
source and test group given as the column name. The connection
between each column’s source abbreviation and its related
dataset(s) and article(s) are given in table 2. Some sets lack
measurements for certain genes, in which case a grey marking is
used.
(TIF)
Table S1 A table listing the detailed sample description for all
samples included in the microarray analysis.
(PDF)
Table S2 The full results from the limma analysis of the
NTNU data. P-values given are benjamini-hochberg corrected
for multiple comparisons.
(XLS)
Table S3 csv – Comma separated values. Over-represent-
ed Gene Ontology terms in the Crohn’s disease-specific gene co-
expression network.
(CSV)
Table S4 csv – Comma separated values. Over-represent-
ed Gene Ontology terms in the Ulcerative colitis-specific gene co-
expression network.
(CSV)
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